DUPONT DE NEMOURS INC (DD)       68.93  +1.38 (+2.04%)

68.93  +1.38 (+2.04%)

US26614N1028 - Common Stock - After market: 68.93 0 (0%)


Fundamental Rating

5

Taking everything into account, DD scores 5 out of 10 in our fundamental rating. DD was compared to 123 industry peers in the Chemicals industry. While DD has a great profitability rating, there are some minor concerns on its financial health. While showing a medium growth rate, DD is valued expensive at the moment.




Profitability

Profitability Rating

7

DD has a Return On Assets of 14.19%. This is better than the industry average of 7.57%.
DD has a Return On Equity of 22.09%. This is better than the industry average of 19.27%.

DD has a Profit Margin of 45.08%. This is amongst the best returns in the industry. The industry average is 8.83%. DD outperforms 100% of its industry peers.
The Piotroski-F score of DD is 7.00. This is a strong score and indicates good health and profitability for DD.
VS Industry

ROA (14.19%) VS Industry: 78% outperformed.

0.23
624.60

ROE (22.09%) VS Industry: 64% outperformed.

0.26
237.19

Profit Margin (45.08%) VS Industry: 100% outperformed.

0.51
45.08

Valuation

Valuation Rating

2

When comparing the price book ratio of DD to the average industry price book ratio of 1.80, DD is valued rather cheaply.
The Price/Earnings Ratio is 20.21, which indicates a rather expensive current valuation of DD.
The Forward Price/Earnings Ratio of 17.74 indicates a rather expensive current valuation of DD.
The PEG Ratio, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

With a price book ratio of 1.29, DD is valued correctly.
With a Price/Earning Ratio of 20.21, DD is valued a higher than the industry average, which is at 11.76. 80% of the companies listed in the same industry are cheaper than DD!
Compared to an average industry Enterprise Value to EBITDA ratio of 8.95, DD is valued more expensive than its industry peers.
VS Industry

Price/Earnings (20.21) VS Industry: 20% outperformed.

178.57
1.93

Price/Book (1.29) VS Industry: 70% outperformed.

764.36
0.02

Enterprise Value/ EBITDA (11.19) VS Industry: 37% outperformed.

13,692.96
1.61

Growth

Growth Rating

5

DD shows a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 40.45% yearly.
Based on estimates for the next 5 years, DD will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.38% on average per year.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
DD shows a decrease in Revenue. In the last year, the revenue decreased by -3.76%.

The Revenue has been growing slightly by 2.21% on average over the past 5 years.
The Revenue is expected to grow by 4.77% on average over the next 5 years.
DD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.81%.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS40.45% -14.21% -18.81% 13.94% 15.11% 14.13% 12.38%
Revenue2.21% -15.42% -3.76% -3.08% 0.57% 1.75% 4.77%

Health

Health Rating

5

A Current Ratio of 3.02 indicates that DD has no problem at all paying its short term obligations.
The Current Ratio of DD is much better than the industry average of 2.02.
A Quick Ratio of 2.40 indicates that DD has no problem at all paying its short term obligations.
DD is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.32.

With a Debt to Equity ratio of 0.29, DD is doing better than the averages in the industry. The industry average is at 0.58.
DD has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for DD.
Based on the Altman-Z score of 1.37, we must say that DD is in the distress zone and has some risk of bankruptcy.
When comparing the Altman-Z score of DD to the average industry Altman-Z score of 2.51, DD is less financially healthy than its industry peers.
VS Industry

Debt/Equity (0.29) VS Industry: 66% outperformed.

53.61
0.00

Quick Ratio (2.4) VS Industry: 77% outperformed.

0.01
65.94

Current Ratio (3.02) VS Industry: 72% outperformed.

0.01
65.94

Altman-Z (1.37) VS Industry: 27% outperformed.

-529.46
152.09

Dividend

Dividend Rating

5

11.11% of the earnings are spent on dividend by DD. This is a low number and sustainable payout ratio.
DD has been paying a dividend for at least 10 years, so it has a reliable track record.
DD has a Yearly Dividend Yield of 2.05%. Purely for dividend investing, there may be better candidates out there.

Compared to an average industry Dividend Yield of 2.25, DD has a dividend in line with its industry peers.
DD's Dividend Yield is comparable with the S&P500 average which is at 2.55.
The dividend of DD decreases each year by -15.14%.
VS Industry

Dividend Yield (2.05%) VS Industry: 46% outperformed.

0.30
22.94

DUPONT DE NEMOURS INC68.93

NYSE:DD (3/20/2023, 8:04:00 PM)+1.38 (+2.04%)

After market: 68.93 0 (0%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Chemicals
Earnings (Last) 02-07 2023-02-07/bmo Earnings (Next) 05-01 2023-05-01/bmo
Inst Owners 74.05% Inst Owner Change 2.76%
Ins Owners 0.16% Ins Owner Change 15.81%
Market Cap 34.24B Analysts 78.62
Price Target 87.31 (26.66%)

Dividend
Industry RankSector Rank
Dividend Yield 2.05%
Dividend Growth(5Y) -15.14% DP 11.11%
Div Incr Years 1 Div Non Decr Years 2
Ex-Date 02-27 2023-02-27 (0.36)

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 5.49%
Min EPS beat(2) 0.38% Max EPS beat(2) 10.6%
EPS beat(4) 4 Avg EPS beat(4) 11.01%
Min EPS beat(4) 0.38% Max EPS beat(4) 19.36%
Revenue beat(2) 1 Avg Revenue beat(2) -1.01%
Min Revenue beat(2) -2.45% Max Revenue beat(2) 0.42%
Revenue beat(4) 1 Avg Revenue beat(4) -0.96%
Min Revenue beat(4) -2.45% Max Revenue beat(4) 0.42%
PT rev (1m) 1.45% PT rev (3m) 9.74%
EPS NQ rev (1m) -8.66% EPS NQ rev (3m) -10.43%
EPS NY rev (1m) -1.47% EPS NY rev (3m) -1.47%
Revenue NQ rev (1m) -5.11% Revenue NQ rev (3m) -5.93%
Revenue NY rev (1m) -2.69% Revenue NY rev (3m) -2.69%

Valuation
Industry RankSector Rank
PE 20.21
Fwd PE 17.74
P/S 2.63
P/FCF N/A
P/OCF 58.24
P/B 1.29
P/tB 7.76
EV/EBITDA 11.19
EPS(TTM) 3.41 EY 4.95%
EPS(NY) 3.89 Fwd EY 5.64%
FCF(TTM) -0.31 FCFY N/A
OCF(TTM) 1.18 OCFY 1.72%
SpS 26.2 BVpS 53.48
TBVpS 8.88 PEG (NY) 1.45
PEG (5Y) 0.5

Profitability
Industry RankSector Rank
ROA 14.19%
ROE 22.09%
ROIC 4.26%
ROICexc 4.9%
ROICexgc 15.25%
OM 15.69%
PM 45.08%
GM 35.45%
ROICexgc(3y) 10.16% ROICexcg growth 3Y 0.55%
ROICexcg growth 5Y N/A ROICexc(3y) 3.58%
ROICexc growth 3Y 11.26% ROICexc growth 5Y N/A
OM growth 3Y 6.64% OM growth 5Y N/A
PM growth 3Y 169.22% PM growth 5Y 35.64%
GM growth 3Y 0.76% GM growth 5Y 14.38%
F-Score 7 Asset Turnover 0.31

Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA 2.51
Cap/Depr 62.97%
Profit Quality N/A
Current Ratio 3.02
Quick Ratio 2.4
Altman-Z 1.37
F-Score 7 WACC 8.81%
ROIC/WACC 1.73 Cap/Depr(3y) 54.22%
Cap/Depr(5y) 61.06% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -18.81% EPS 3Y -14.21%
EPS 5Y 40.45% EPS growth Q2Q -17.59%
EPS Next Y 13.94% EPS Next 2Y 15.11%
EPS Next 3Y 14.13% EPS Next 5Y 12.38%
Revenue growth 1Y -3.76% Revenue growth 3Y -15.42%
Revenue growth 5Y 2.21% Revenue growth Q2Q -4.37%
Revenue Next Year -3.08% Revenue Next 2Y 0.57%
Revenue Next 3Y 1.75% Revenue Next 5Y 4.77%
EBIT growth 1Y 0.15% EBIT growth 3Y -9.8%
EBIT growth 5Y N/A EBIT Next Year 17.04%
EBIT Next 3Y 11.06% EBIT Next 5Y 13.67%
FCF growth 1Y -111.15% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y -74.22%
OCF growth 3Y -25.27% OCF growth 5Y N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA